Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Sleep disturbances and daytime sleepiness are well‐known phenomena in Parkinson's disease (PD). Fifteen previously untreated PD patients underwent clinical evaluation, subjective sleep evaluation and polysomnographic evaluation (PSG) before and after a treatment period of mean 8 ± 3.1 months with dopaminergic drugs. Both mean Unified Parkinson's Disease Rating Scale (UPDRS) total score and mean subset III of the UPDRS were significantly improved with dopaminergic treatment. PSG revealed that administration of dopaminergic drugs resulted in significant increase in mean percentage of stages 1 and 2. The mean Epworth Sleepiness Scale (ESS) score was significantly increased and mean Multiple Sleep Latency Test (MSLT) score was significantly decreased after dopaminergic treatment indicating subjective and objective daytime sleepiness. The differences in MSLT scores were best explained by a higher dose of l‐dopa, whereas other variables such as disease duration, treatment duration, Hoehn and Yahr stage, sleep efficiency index or dopamine agonists did not increase the significance. In contrast, any of the variables appeared to explain ESS score variability. This study demonstrates that daytime sleepiness is not present in untreated patients but emerges later during dopaminergic treatment. Total daily l‐dopa dose is predictive of objective daytime sleepiness. Furthermore, subjective assessment of sleepiness may cause underestimation of the severity of daytime sleepiness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
The Nighttime Problems of Parkinsonʼs Disease
Lees, A. J., Blackburn, N. A., & Campbell, V. L. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198812000-00004 · Cited by 444
Nausieda, P. A., Weiner, W. J., Kaplan, L. R., Weber, S., & Klawans, H. L. (1982) · Clinical Neuropharmacology · doi:10.1097/00002826-198205020-00003 · Cited by 245 · cited 3×
“It has been also observed with L-dopa treatment (Nausidea et al., 1982).”
Background
Cited by
Iranzo, A., Santamaria, J., & Tolosa, E. (2009) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.11.003 · Cited by 290
Medeiros, C. A. M., Carvalhedo de Bruin, P. F., Lopes, L. A., Magalhães, M. C., de Lourdes Seabra, M., & Sales de Bruin, V. M. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0390-x · Cited by 269
Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations
Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., et al. (2010) · Movement Disorders · doi:10.1002/mds.23190 · Cited by 268
Circadian and sleep disorders in Parkinson's disease
Videnovic, A., & Golombek, D. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.018 · Cited by 245
“EDS is uncommon in newly diagnosed, untreated PD patients (Fabbrini et al. 2002, Kaynak et al. 2005); however, a significant number of these patients developed EDS during the first year of therapy.”
BackgroundThe nonmotor symptoms of Parkinson's disease—An overview
Lim, S., & Lang, A. E. (2010) · Movement Disorders · doi:10.1002/mds.22786 · Cited by 171
“A prospective study found that treatment-naı̈ve patients with mild-to-moderate PD developed daytime sleepiness only after commencing dopaminergic medication.(65) Furthermore, L-dopa(66) and dopamine agonists(67)”
Background
Metadata
- Authors
- Kaynak, D., Kiziltan, G., Kaynak, H., Benbir, G., & Uysal, O.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2005-02-03
- Volume
- 12
- Issue
- 3
- Pages
- 199-207
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2072638800
- Cited by
- 131
- References
- 4
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. https://app.cochat.ai/papers/10.1111/j.1468-1331.2004.00971.x
- The paper
- Kaynak, D., Kiziltan, G., Kaynak, H., Benbir, G., & Uysal, O. (2005). Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2004.00971.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.